NCT00600028View on ClinicalTrials.gov

Treatment of Chronic Cough in Idiopathic Pulmonary Fibrosis With Thalidomide

PHASE3CompletedINTERVENTIONAL
Enrollment

25

Participants

Timeline

Start Date

December 31, 2007

Primary Completion Date

September 30, 2011

Study Completion Date

September 30, 2011

Conditions
Idiopathic Pulmonary FibrosisCough
Interventions
DRUG

Thalidomide

Thalidomide 50 - 100 mg by mouth daily

DRUG

Placebo

Placebo 50-100 mg by mouth per day

Trial Locations (1)

21224

Johns Hopkins Bayview Medical Center, Baltimore

All Listed Sponsors
lead

Johns Hopkins University

OTHER

NCT00600028 - Treatment of Chronic Cough in Idiopathic Pulmonary Fibrosis With Thalidomide | Biotech Hunter | Biotech Hunter